Millennium Management’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,425
| Closed | -$259K | – | 5401 |
|
|
2023
Q1 | $259K | Buy |
21,425
+3,598
| +20% | +$43.5K | ﹤0.01% | 3743 |
|
|
2022
Q4 | $81K | Buy |
17,827
+105
| +0.6% | +$477 | ﹤0.01% | 4354 |
|
|
2022
Q3 | $116K | Sell |
17,722
-5,997
| -25% | -$39.3K | ﹤0.01% | 4651 |
|
|
2022
Q2 | $256K | Buy |
+23,719
| New | +$256K | ﹤0.01% | 4338 |
|
|
2022
Q1 | – | Sell |
-2,868
| Closed | -$103K | – | 6165 |
|
|
2021
Q4 | $103K | Sell |
2,868
-8,889
| -76% | -$319K | ﹤0.01% | 4865 |
|
|
2021
Q3 | $864K | Buy |
+11,757
| New | +$864K | ﹤0.01% | 3781 |
|
|
2021
Q2 | – | Sell |
-8,008
| Closed | -$2.33M | – | 5561 |
|
|
2021
Q1 | $2.33M | Sell |
8,008
-637
| -7% | -$185K | ﹤0.01% | 2708 |
|
|
2020
Q4 | $5.4M | Buy |
+8,645
| New | +$5.4M | ﹤0.01% | 1845 |
|